Amneal Pharmaceuticals Inc

NAS:AMRXHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$19.84+2.48%At closeAt close · Wed 21 Oct · ≈ AED 72.86 · Market cap $6.34B · Next earnings Thu 29 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	31.5%	36.7%	35.8%	36.1%	36.5%	37.6%	—	—
Operating margin	4.6%	7.3%	−4.3%	8.5%	8.9%	14.0%	14.0%	+0.0 pts
Net margin	4.6%	0.5%	−5.9%	−3.5%	−4.2%	2.4%	2.4%	+0.0 pts
EBITDA margin	17.3%	19.2%	19.9%	20.9%	15.7%	20.0%	—	—
Return on equity	30.0%	2.9%	−43.6%	−424.6%	107.0%	−101.8%	1,208.4%	+1310.2 pts
Return on assets	2.3%	0.3%	−3.4%	−2.4%	−3.3%	2.0%	2.0%	+0.0 pts
Return on capital employed	2.7%	4.7%	−3.1%	7.8%	10.5%	15.1%	—	—
Debt / equity	9.9×	8.0×	9.5×	139.0×	−23.7×	−38.7×	458.9×	+1287.2%
Debt / assets	74.9%	73.0%	74.9%	79.2%	74.1%	74.4%	—	—
Interest coverage	0.6×	1.1×	−0.6×	1.0×	1.0×	1.8×	—	—
Current ratio	2.3×	2.2×	1.9×	1.6×	1.4×	2.2×	2.2×	+0.0%
Quick ratio	1.6×	1.5×	1.2×	0.9×	0.9×	1.5×	—	—
Cash ratio	0.5×	0.4×	0.0×	0.1×	0.1×	0.4×	0.4×	+0.0%
Asset turnover	0.5×	0.5×	0.6×	0.7×	0.8×	0.8×	—	—
Inventory turnover	2.8×	2.7×	2.7×	2.6×	2.9×	3.1×	—	—
Receivables turnover	3.1×	3.0×	3.0×	3.7×	3.6×	3.2×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.